Certara, Inc.’s (NASDAQ:CERT) Share Price Not Quite Adding Up
When close to half the companies in the Healthcare Services industry in the United States have price-to-sales ratios (or “P/S”) below 2.2x, you may consider Certara, Inc. (NASDAQ:CERT) as a stock to avoid entirely with its 4.6x P/S ratio. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.
Check out our latest analysis for Certara
What Does Certara’s P/S Mean For Shareholders?
With revenue growth that’s inferior to most other companies of late, Certara has been relatively sluggish. Perhaps the market is expecting future revenue performance to undergo a reversal of fortunes, which has elevated the…
